ArticleBMC urology2026

Durable complete metabolic response to enfortumab vedotin plus pembrolizumab in metastatic upper tract urothelial carcinoma: a case report.

Melike Dönmez Tekin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.